IMCC
IM Cannabis Corp.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$1.50
+7.91%Margins
Gross margin
13.8%
EBITDA margin
-19.9%
EBIT margin
-26.0%
Net margin
-38.1%
FCF margin
-5.8%
284.1%
Return on equity
-63.7%
Return on assets
-129.3%
Return on invested capital
1.71x
Asset turnover
-$1.7M
Cash from operations
$1.99
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026